Search the Newsreel

Genertec Universal Medical Subsidiary to Issue Second Tranche of RMB Medium-Term Notes

Medpace (MEDP) Stock May Sit Below Fair Value While Earnings Look Rich

Journey Medical (FBIO) Q2 2026 Earnings Call: Revenue Rises 23% as Emrosi Accelerates

Journey Medical (FBIO) reported a 23% year-over-year revenue increase to $18.5 million in Q2 2026, primarily driven by strong performance from its rosacea product, Emrosi, which generated $8.1 million in net revenue and saw a 20% sequential rise in prescriptions. The company achieved positive …

National CineMedia, Inc. (NASDAQ:NCMI) Given Average Rating of "Hold" by Brokerages

National CineMedia, Inc. (NASDAQ:NCMI) has received a consensus "Hold" rating from six analysts, with an average 12-month price target of $4.81. The company recently reported quarterly results that missed expectations, with a $0.10 per-share loss and revenue of $58.4 million. An insider sold 12,058 …

Avita Medical Stock Price Forecast. Should You Buy AVH.AX?

Utah Medical Products (NASDAQ:UTMD) Shares Pass Above 200 Day Moving Average - Time to Sell?

Utah Medical Products (NASDAQ:UTMD) shares have risen above their 200-day moving average, reaching $72.37 against an average of $66.51. The company reported quarterly earnings of $0.84 per share on $8.53 million in revenue and declared a $0.31 quarterly dividend, equivalent to a 1.7% annual …

Atria Investments Inc Has $1.01 Million Position in Medpace Holdings, Inc. $MEDP

Atria Investments Inc significantly reduced its stake in Medpace Holdings, Inc. (NASDAQ:MEDP) by 66.2% in the second quarter, now holding 1,907 shares valued at approximately $1.01 million. Despite insider sales totaling $30.88 million, Medpace reported strong quarterly earnings of $4.25 per share, exceeding estimates, …

Asset Management One Co. Ltd. Purchases New Position in Medical Properties Trust, Inc. $MPT

Asset Management One Co. Ltd. has acquired a new stake in Medical Properties Trust, Inc. (NYSE:MPT), purchasing 699,754 shares valued at approximately $3.23 million. This new position represents a 0.12% ownership in the company. Medical Properties Trust recently reported quarterly EPS of $0.15 and …

Medallion Financial (NASDAQ:MFIN) Stock Price Passes Above 200 Day Moving Average - Should You Sell?

Medallion Financial (MFIN) shares have surpassed their 200-day moving average, trading at $11.43 against an average of $9.72. Despite this, analysts maintain a "Hold" rating with a $10.50 target price, which is below the current trading level. The company recently exceeded earnings and revenue …

CONMED Corporation $CNMD Stock Holdings Lessened by Amundi

Amundi significantly reduced its stake in CONMED Corporation (NYSE:CNMD) by 99.7% in the first quarter, selling over 2.29 million shares. Despite this, other major investors increased their holdings, and CONMED surpassed earnings and revenue expectations. However, analysts maintain a cautious "Reduce" rating with a …

OneMedNet (ONMD) Earnings Date and Reports 2026

Fischer Medical Ventures Q1 Consolidated Net Profit Declines To ₹3.8 Crore From ₹5 Crore YoY

Profound Medical Corp. Share Price Live Today – NASDAQ:PROF Stock Price, Chart, News, History

Apyx Medical Corporation (APYX) Stock Falls on Q2 2026 Earnings

Banca Mediolanum S.p.A.: prezzo obiettivo e consensus degli analisti| BMED | IT0004776628| MarketScreener Italia

Key facts: MediWound Ltd. (MDWD) Q2 $3.09M rev; EscharEx $4B target

MediWound Ltd. (MDWD) reported Q2 2026 revenue of $3.09–3.10M, with a net loss of $7.39M and shares down 5.4% for the quarter. The company stated that its therapy, EscharEx, is targeting a $4 billion U.S. non-surgical tissue repair market, which it identifies as its …

SomnoMed Trims FY26 Revenue and Names a Sole CEO as Europe Weighs on the Sleep Play

Penthrox powers Medical Developments International (ASX:MVP) back to positive cash flow as paediatric approvals land

Strata critical medical director Reginald Love disposes of $29,273 in stock

Reginald Love, a director at Strata Critical Medical (NASDAQ:SRTA), sold 5,091 shares of the company's Class A common stock for a total of $29,273 on August 10, 2026. Following this transaction, Love still directly holds 146,481 shares. The company's stock has seen significant gains …

CorMedix Inc (NASDAQ:CRMD) Receives Average Rating of "Moderate Buy" from Brokerages

CorMedix Inc (NASDAQ:CRMD) has received an average "Moderate Buy" rating from brokerages, with six out of eight analysts recommending a buy and two recommending a hold. The company's average 12-month price target is $14.86. This follows a strong second quarter where CorMedix beat revenue …

Rockwell Medical Releases Q2 2026 Financial Results

Rockwell Medical, Inc. announced strong Q2 2026 financial results, significantly beating Wall Street expectations with an adjusted loss per share of $0.04 against an estimated $0.24 loss. The company reported revenue of $17.8 million, an 11% increase year-over-year, driven by expanding demand for its …

ImpediMed Limited (ASX:IPD)Chases FY28 Breakeven for SOZO as Capital Raise Resets the Balance Sheet

Nova Eye Medical (ASX:EYE)Turns the Corner on Profit as US Glaucoma Sales Surge

Parabilis Medicines (PBLS) boosts cash above $1.1B after IPO and Regeneron deal

Parabilis Medicines, Inc. reported its Q2 2026 results, showing a significant increase in cash and cash equivalents to over $1.1 billion. This boost follows its June 2026 IPO, which generated $787.9 million in net proceeds, and a $50.0 million upfront payment from its collaboration …

Earnings call transcript: Amagi Media Labs posts strong Q1 2026 growth

Bodhi Tree Multimedia consolidated net profit rises 46.51% in the June 2026 quarter

SBC Medical Reports 13 Pct Rise In Q2 Revenue, Net Income Jumps 335 Pct

SBC Medical Group Holdings Inc. reported a 13% year-on-year increase in consolidated revenue to US$49 million for Q2 fiscal 2026, with net income surging by 335% to US$11 million. The company attributes this growth to strengthening underlying fundamentals, including the integration of healthcare and …

Medico Remedies standalone net profit rises 38.46% in the June 2026 quarter

Sanara MedTech (SMTI) Stock Stays Quiet As Profitability Meets Debt Scrutiny

Sanara MedTech (SMTI) recently turned profitable in Q2 2026, reporting net income of US$0.40m from continuing operations, a significant improvement from a loss in the prior year. Despite this positive shift and increased revenue, the stock's reaction was muted, with concerns remaining over thin …

Trump Media's CFO Sells Nearly 20,000 Shares After the Company's Crypto Business Combination Collapsed

Key Points The transaction involved 18,817 shares at a weighted average price of $8.33 per share, representing a total value of ~$157,000 on August 13, 2026. The move reduced the executive's direct equity holdings by 3% while maintaining a total beneficial position of ~582,000 …

MediciNova (MNOV) Reports Q2 Loss, Tops Revenue Estimates

MediciNova (MNOV) reported a Q2 loss of $0.05 per share, surpassing the Zacks Consensus Estimate of a $0.06 loss and improving from a $0.07 loss a year ago. The company also exceeded revenue estimates, posting $0.46 million against a $0.15 million consensus, though its …

OUTFRONT Media (OUT), What Is Behind Its Latest Attention?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Why OUTFRONT Media's latest earnings and deals matter for investors OUTFRONT Media (OUT) has been in focus after reporting second quarter 2026 results, raising …

ICU Medical (ICUI) investor to sell 5,417 shares worth $982K on NASDAQ

ICU Medical shareholder Daniel Woolson plans to sell 5,417 shares of common stock, valued at $982,264.61, on NASDAQ by August 13, 2026. This sale follows a previous transaction three months prior where Woolson sold 2,123 shares for $280,684.80. The shares originate from various performance …

Parabilis Medicines (PBLS) Earnings Date and Reports 2026

How Investors May Respond To ResMed (RMD) Dividend Hike And Ventilator Recall Headwinds

ResMed Inc. recently announced increased fourth-quarter and full-year sales, a quarterly dividend hike to US$0.66 per share, and the completion of a US$1.40 billion share buyback program. However, these positive developments are overshadowed by a softer outlook due to an FDA Class 1 recall …

Form 8K Parabilis Medicines For: 13 August By Investing.com

The article is a brief financial news item from Investing.com, reporting on a Form 8K filing by Parabilis Medicines for August 13th. It provides no further details beyond stating the filing occurred on that date.